You may qualify to participate in a study of an investigational treatment for patients with PAD and non-healing wounds if you are between 18-80 years old with a diagnosis of critical limb ischemia.
This study seeks to determine if treatment with adult stem cells, taken from the patient’s own bone marrow, can improve healing and prevent amputation.
This study is being conducted at Kansas City Vascular Foundation, by Dr. Karl Stark MD, FACS.
The title of the study is: An open-label single arm phase 2 study to assess the efficacy and safety of ASCT01 (autologous stem cell transplanattion) in patients with Critical Limb Ischemia, sponsored by Lifecells LLC.
Participants will undergo a screening process to see if they qualify. Qualified subjects will spend 1 day in the hospital during the initial study period and will have an additional 5 outpatient visits over the following year. All study procedures will be provided at no cost.
For additional details and enrollment screening for the study please contact: